Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: J&J MedTech ordered to pay $147M | Changing employment models | FDA wants new heart warnings on COVID vaccines

News You Need to Know Today
Week in Review: J&J MedTech ordered to pay $147M | Changing employment models | FDA wants new heart warnings on COVID vaccines
Saturday, May 24, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.

READ MORE >
money court scale of justice ruling legal settlement
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Share on Twitter Share on Facebook Share on Linkedin
money court scale of justice ruling legal settlement
The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.
READ MORE >

Cardiology employment models undergoing a dramatic shift

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

READ MORE >
Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology employment models undergoing a dramatic shift

Share on Twitter Share on Facebook Share on Linkedin
Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
READ MORE >

Medtronic gains a key approval for Evolut TAVR valves

More patients can now undergo redo TAVR with a Medtronic valve than ever before.

READ MORE >
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains a key approval for Evolut TAVR valves

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
More patients can now undergo redo TAVR with a Medtronic valve than ever before.
READ MORE >

Same-day discharge after TAVR linked to positive outcomes

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after TAVR linked to positive outcomes

Share on Twitter Share on Facebook Share on Linkedin
When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.
READ MORE >

FDA wants new heart damage warnings added to COVID-19 vaccines

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

READ MORE >
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
Share on Twitter Share on Facebook Share on Linkedin

FDA wants new heart damage warnings added to COVID-19 vaccines

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.
READ MORE >

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

READ MORE >
robotic PCI Corindus CorPath GRX
Share on Twitter Share on Facebook Share on Linkedin

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Share on Twitter Share on Facebook Share on Linkedin
robotic PCI Corindus CorPath GRX
Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.
READ MORE >

2 out of 5 heart failure patients are not seeing a cardiologist

Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

2 out of 5 heart failure patients are not seeing a cardiologist

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.
READ MORE >

Medtronic to spin off its diabetes business

One of the world's largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes business, would be the new company's CEO.

READ MORE >
spin off spinoff separate business new direction new path
Share on Twitter Share on Facebook Share on Linkedin

Medtronic to spin off its diabetes business

Share on Twitter Share on Facebook Share on Linkedin
spin off spinoff separate business new direction new path
One of the world's largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes business, would be the new company's CEO.
READ MORE >

Cardiologists make history, use new robotic imaging system for first time

Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.

READ MORE >
ROB’E Robotic transesophageal echocardiography (TEE). ROB’E, a German startup, has developed a new remote-controlled robotic (RCR) system with these challenges in mind. Users are able to remotely manipulate TEE probes, performing precise movements and even saving specific positions so they can be duplicated as needed.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, use new robotic imaging system for first time

Share on Twitter Share on Facebook Share on Linkedin
ROB’E Robotic transesophageal echocardiography (TEE). ROB’E, a German startup, has developed a new remote-controlled robotic (RCR) system with these challenges in mind. Users are able to remotely manipulate TEE probes, performing precise movements and even saving specific positions so they can be duplicated as needed.
Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.
READ MORE >

IVL delivers significant value for women, real-world data confirm

Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

READ MORE >
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Share on Twitter Share on Facebook Share on Linkedin

IVL delivers significant value for women, real-world data confirm

Share on Twitter Share on Facebook Share on Linkedin
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup